The EACR and the Pezcoller Foundation were delighted to present the 2016 Pezcoller Foundation – EACR Cancer Researcher Award to Professor Yardena Samuels (Department of Molecular Cell Biology and Director, Ekard Institute for Cancer Diagnosis Research, MICC, Israel).
The Samuels laboratory uses various sequencing approaches to identify the genetic changes that underlie melanoma. Once these mutations are identified, her group focuses on characterising the biochemical, functional, and clinical aspects of the most highly mutated genes.
The Pezcoller Foundation and EACR were pleased to award the 2014 Pezcoller Foundation – EACR Cancer Researcher Award to Professor Eduard Batlle from the Institute for Research in Biomedicine (IRB Barcelona), Spain.
In 2004, Eduard Batlle joined the Institute for Research in Biomedicine (IRB Barcelona) as Head of the Oncology Program and ICREA Research Professor. The research activity in his lab is focused towards the characterization of the mechanisms that drive colorectal cancer initiation and progression. In the last ten years and amongst other findings, the Batlle laboratory has made key contributions to understand how stem cell gene programs control the behavior of tumor cells and impose a hierarchical organization on colorectal cancer. More recently, he has investigated the phenomenon of metastasis and particularly how disseminated tumor cells depend upon signals from the tumor microenvironment for survival during colonization of foreign organs.
EACR was pleased to award Eric So (King's College London, UK) with the Pezcoller Foundation - EACR Cancer Researcher Award Lecture, which was presented for the first time at EACR-22 and will be presented at future EACR biennial congresses. Professor So received a prize of €10,000 and gave the prestigious Pezcoller Foundation – EACR Award Lecture at EACR-22, on Saturday 7th July.
The primary goal of Eric So's research program is to characterize the mechanisms of transcriptional regulation that are corrupted in leukaemia. By identification and molecular dissection of the transcriptional and epigenetic networks deregulated by oncogenic transcription factors, the research work should give important mechanistic insights into the molecular basis of the diseases, and in longer term, provide fruitful avenues for development of specific therapeutic interventions.
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.